Facet Hypertrophy | Diagnosis & Disease Information
WEBSep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or …
Hydroxyapatite Crystal Deposition Disease (HADD)
WEBNov 15, 2022 · Hydroxyapatite deposition disease (HADD) is a condition where hydroxyapatite crystals accumulate in the soft tissues surrounding joints, leading to inflammation, tenderness, and pain. It primarily affects women around the age of 45 and commonly affects the glenohumeral joint in the shoulder. Other joints such as the hip, knee, elbow, wrist, and ...
Viscosupplementation for Knee Osteoarthritis - Rheumatology …
WEBMar 25, 2019 · Viscosupplementation is a medical procedure during which a gel-like fluid called hyaluronic acid is injected into the knee joint. Hyaluronic acid is a naturally occurring lubricant that allows for smoother joint movement. It is found in lower concentrations in patients with knee osteoarthritis.
Ehlers-Danlos Syndrome - Rheumatology Advisor
WEBEhlers-Danlos syndrome is a group of inherited connective tissue disorders that primarily affects the skin, joints, and blood vessel walls 1 but can affect every organ system and result in significant morbidity and mortality. 2 Typical clinical manifestations are skin hyperelasticity, hypermobility of joints, the fragility of blood vessels, 2 ...
2022 ACR/AAHKS Guidelines for Management of
WEBApr 6, 2022 · The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) released updated guidelines for the perioperative management of antirheumatic medications among patients with rheumatic diseases undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA).
Living With and Treating Gout: A Podiatrist’s Experience
WEBFeb 3, 2021 · Living With Gout. As a 23-year-old avid athlete, I was far from an obvious candidate for a gout diagnosis. When I started experiencing flares of severe pain in my foot, I wrote it off as a sports injury, not thinking it could be something more serious. Little did I know at the time, I was one of the 9.2 million 1 people in America who was ...
Rheumatoid Arthritis Injection Treatment Approved by FDA
WEBJune 5, 2017. Regeneron Pharmaceuticals, Inc., and Sanofi announced that the US Food and Drug Administration (FDA) has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis (RA). This treatment is recommended in patients with RA who have had an inadequate response or demonstrated intolerance to one ...
Raynaud's Syndrome | Diagnosis & Disease Information
WEBAug 4, 2022 · Raynaud’s syndrome, or Raynaud’s phenomenon, is a rare disorder that affects the cutaneous arterioles and can cause them to abnormally vasoconstrict, temporarily limiting blood flow. The most common symptoms are episodes of coldness, numbness, and tingling in the fingers or toes. First described by Maurice Raynaud in …
Updated 2019 ACR Recommendations for Treatment of …
WEBSep 9, 2019 · Based on new evidence and an expert consensus, the American College of Rheumatology (ACR), the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network released updated recommendations for the treatment of axial spondyloarthritis (SpA), which comprises ankylosing spondylitis (AS) and nonradiographic axial SpA.
Choosing the Right TNF Inhibitor Therapy for Rheumatoid Arthritis
WEBDecember 20, 2017. Biologics, approved nearly 20 years ago for the treatment of rheumatoid arthritis (RA), transformed treatment, and tumor necrosis factor inhibitors (TNFis) are now usually the first and most frequently used biologics. 1. Although all TNFis block TNFα and are broadly similar in efficacy and toxicity, resulting in little ...